Tasigna and Olanzapine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tasigna (nilotinib hydrochloride monohydrate) and Olanzapine (olanzapine). Common drug interactions include vertebral artery stenosis among females and eyelid oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Tasigna and Olanzapine. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Tasigna?

Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 31,535 Tasigna users. Check the latest studies of Tasigna.

What is Olanzapine?

Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,242 Olanzapine users. Check the latest studies of Olanzapine.

On Jul, 06, 2026

20 people who take Tasigna and Olanzapine together, and have interactions are studied.

Tasigna and Olanzapine drug interactions.

What are the common drug interactions of Tasigna and Olanzapine, by gender? *:

female:

Vertebral artery stenosis (abnormal narrowing of vertebral artery)
Arthralgia (joint pain)
Carotid arteriosclerosis (plaque deposition in artery)
Carotid artery occlusion (artery blockage)
Carotid bruit (sound heard over the carotid artery area during auscultation)
Carotid intima-media thickness increased (increased thickness of carotid artery muscle)
Cerebral artery stenosis (hardening of brain blood vessels)
Drug intolerance (drug sensitivity)
Gait disturbance
Myalgia (muscle pain)

male:

Eyelid oedema (eyelids are swollen and contain excessive fluid)
Folliculitis (infection of hair root)
Non-cardiac chest pain
Rash
Swelling

What are the common drug interactions of Tasigna and Olanzapine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Eyelid oedema (eyelids are swollen and contain excessive fluid)
Folliculitis (infection of hair root)
Non-cardiac chest pain
Rash
Swelling

30-39:

n/a

40-49:

Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)
Lymphoma (cancer that begins in immune system cells)
Blood bilirubin increased
Blood lactate dehydrogenase increased
Glomerular filtration rate decreased
Haemoglobin decreased

50-59:

Carotid artery stenosis (narrowing of carotid artery)
Basilar artery stenosis (abnormal narrowing of basilar artery)
Cerebral artery stenosis (hardening of brain blood vessels)
Drug intolerance (drug sensitivity)
Gait disturbance
Myalgia (muscle pain)
Nocturnal dyspnoea (attacks of severe shortness of breath and coughing that generally occur at night)
Vertebral artery hypoplasia (incomplete or arrested development of vertebral artery)
Disease progression
Subclavian artery stenosis (the abnormal narrowing of subclavian artery)

60+:

n/a

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 17 people, 85.00%
Psychotic Disorder: 10 people, 50.00%
Depression: 5 people, 25.00%
Chronic Myeloid Leukaemia (In Remission): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tasigna and Olanzapine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously